A new report has outlined two new gene therapies that could be used to treat a rare disease called MPS I.
Researchers at the Perelman School of Medicine at the University of Pennsylvania analysed ways to deliver a vector to replace the enzyme IDUA, which patients with the disorder are deficient in. Read the rest of this entry »
A protein – alpha-synuclein – is known to play a role in the development of Parkinson's disease, as well as other neurological conditions, such as dementia with Lewy bodies.
However, much has been unknown about the protein's functions and insight in this area could lead to new therapies. Read the rest of this entry »
The bakers at Fisher Scientific Loughborough office dusted off their aprons and have been busy baking as part of the biggest coffee morning campaign to raise money for Macmillan Cancer charity.
On Monday 29th September a vast array of scrumptious cakes and biscuits were on sale in their staff restaurant a long with a tombola (prizes donated by employees). Read the rest of this entry »
Researchers have spent years trying to discover more about the brain so they can map it accurately, as it is believed that this will be key to preventing and treating brain disorders like Alzheimer's disease and traumatic neurological injuries.
A study conducted at the Tel Aviv University (TAU) has made a significant contribution to this goal. Read the rest of this entry »
General consensus states that schizophrenia is a brain disorder that alters development, having both genetic and environmental risk factors, which are linked to other neurodevelopmental disorders such as autism and intellectual disability.
Healthy brains develop along a path that is determined by a large network of genes, as well as a wide range of environmental factors. Read the rest of this entry »